LCN2 and diabetic kidney disease: There are several markers for evaluation of DKD; Kidney injury molecule 1 (KIM-1) and Neutrophil gelatinase-associated lipocalin (NGAL) are among the new markers, which based on the Food and Drug Administration (FDA) reports might be appropriate for kidney injury evaluation (9, 10).